^
Association details:
Biomarker:No biomarker
Cancer:Follicular Lymphoma
Drug:cyclophosphamide (Alkylating agent)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
01/20/2021
Excerpt:
Follicular Lymphoma: FIRST-LINE THERAPY FOR EDLERLY OR INFIRM…Other Recommended Regimens…Cyclophosphamide ± rituximab